podophyllotoxin has been researched along with Aerobic Glycolysis, Oncologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Birk, AM; Dheeraj, A; Ghoochani, A; Giaccia, AJ; Going, CC; Kumar, V; LaGory, EL; Le, QT; Li, Y; Malhotra, SV; Nambiar, DK; Pitteri, SJ; Resendez, A; Singh, RP; Sledge, GW; Stoyanova, T; Tailor, D; Ye, J | 1 |
1 other study(ies) available for podophyllotoxin and Aerobic Glycolysis, Oncologic
Article | Year |
---|---|
Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Death; Cell Line, Tumor; Cell Survival; Enzyme Activation; Female; Glucose; Glycolysis; Humans; Lactic Acid; Lipogenesis; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Oxidative Phosphorylation; Podophyllotoxin; Random Allocation; Triple Negative Breast Neoplasms; Warburg Effect, Oncologic | 2021 |